External Trigger Free Charge Switchable Cationic Ligands in the Design of Safe and Effective Universal Heparin Antidote
Advanced Healthcare Materials · 2024
DOI: 10.1002/adhm.202400108 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Chanel C La und 5 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Blood Research, Life Sciences Institute, University of British Columbia, Vancouver, BC, V6T 1Z3, Canada. Hauptthemen laut MEDLINE: Heparin, Cations. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, NHLBI NIH HHS, Natural Sciences and Engineering Research Council of Canada.
Abstract (Originalsprache)
Thrombosis, the formation of blood clots within a blood vessel, can lead to severe complications including pulmonary embolism, cardiac arrest, and stroke. The most widely administered class of anticoagulants is heparin‐based anticoagulants such as unfractionated heparin, low‐molecular weight heparins (LMWHs), and fondaparinux. Protamine is the only FDA‐approved heparin antidote. Protamine has limited efficacy neutralizing LMWHs and no reversal activity against fondaparinux. The use of protamine can lead to complications, including excessive bleeding, hypotension, and hypersensitivity, and has narrow therapeutic window. In this work, a new concept in the design of a universal heparin antidote: switchable protonation of cationic ligands, is presented. A library of macromolecular polyanion inhibitors (MPIs) is synthesized and screened to identify molecules that can neutralize all heparins with high selectivity and reduced toxicity. MPIs are developed by assembling cationic binding groups possessing switchable protonation states onto a polymer scaffold. By strategically selecting the identity and modulating the density of cationic binding groups on the polymer scaffold, a superior universal heparin reversal agent is developed with improved heparin‐binding activity and increased hemocompatibility profiles leading to minimal effect on hemostasis. The activity of this heparin antidote is demonstrated using in vitro and in vivo studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Blood Research, Life Sciences Institute, University of British Columbia, Vancouver, BC, V6T 1Z3, Canada.
- Department of Chemistry, University of British Columbia, Vancouver, BC, V6T 1Z3, Canada.
- Department of Biological Chemistry, University of Michigan Medical School, Ann Arbor, MI, 48109, USA.
- Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, V6T 1Z3, Canada.
- Department of Chemical and Biological Engineering, University of British Columbia, Vancouver, BC, V6T 1Z3, Canada.
- Michael Smith Laboratories, University of British Columbia, Vancouver, BC, V6T 1Z3, Canada.
ORCID-Profile: James H Morrissey, Jayachandran N Kizhakkedathu
Förderung
- CIHR
- NHLBI NIH HHS
- Natural Sciences and Engineering Research Council of Canada
- British Columbia Knowledge Development Fund
- Canada Foundation for Innovation
- Office of Research Infrastructure Programs, National Institutes of Health
- Canadian Institutes of Health Research
Zitieren
APA
La, C. C., Smith, S. A., Kalathottukaren, M. T., Haynes, C. A., Morrissey, J. H., & Kizhakkedathu, J. N. (2024). External Trigger Free Charge Switchable Cationic Ligands in the Design of Safe and Effective Universal Heparin Antidote. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202400108
Vancouver
La CC, Smith SA, Kalathottukaren MT, Haynes CA, Morrissey JH, Kizhakkedathu JN. External Trigger Free Charge Switchable Cationic Ligands in the Design of Safe and Effective Universal Heparin Antidote. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202400108
BibTeX
@article{La2024,
author = {La, Chanel C and Smith, Stephanie A and Kalathottukaren, Manu Thomas and Haynes, Charles A and Morrissey, James H and Kizhakkedathu, Jayachandran N},
title = {External Trigger Free Charge Switchable Cationic Ligands in the Design of Safe and Effective Universal Heparin Antidote},
journal = {Advanced Healthcare Materials},
year = {2024},
doi = {10.1002/adhm.202400108}
}
EUVIMED